晚期胃食管腺癌的当前及新兴靶向治疗 Current and Emerging Targeted Therapy in Advanced Gastroesophageal Adenocarcinoma. PubMed 2026/09/08 发表Pharmaceuticals (Basel)Q1 · IF 5.7(JCR 2025) 靶点:HER2靶点:EGFR靶点:VEGFR技术:CAR-T技术:双特异性抗体地区:欧洲
胃癌中的抗体介导治疗:过去、现在与未来 Antibody-Mediated Therapy in Gastric Cancer: Past, Present, and Future. PubMed 2025/12/15 发表Curr Issues Mol BiolQ2 · IF 4.1(JCR 2025) 靶点:HER2靶点:TROP2靶点:VEGFR技术:CAR-T技术:双特异性抗体胃癌
胃癌的靶向治疗与免疫治疗:合理策略、新进展、挑战与未来展望 Targeted therapy and immunotherapy for gastric cancer: rational strategies, novel advancements, challenges, and future perspectives. PubMed 2025/02/08 发表Mol MedQ1 · IF 8.3(JCR 2025) 靶点:HER2靶点:EGFR靶点:VEGFR技术:溶瘤病毒技术:双特异性抗体胃癌
血液系统恶性肿瘤中靶向 ROR1 的治疗进展 Therapeutic advances in the targeting of ROR1 in hematological cancers. PubMed 2024/11/17 发表Cell Death DiscovQ1 · IF 10.4(JCR 2025) 靶点:HER2靶点:EGFR靶点:ROR1技术:CAR-T技术:双特异性抗体血液系统恶性肿瘤
靶向肿瘤血管以改善经体外 T 细胞衔接双特异性抗体武装的 T 细胞的抗肿瘤活性 Targeting tumor vasculature to improve antitumor activity of T cells armed ex vivo with T cell engaging bispecific antibody. PubMed 2023/03/01 发表J Immunother CancerQ1 · IF 11.7(JCR 2025) 靶点:GD2靶点:HER2靶点:GPC3技术:双特异性抗体神经母细胞瘤骨肉瘤